期刊文献+

冠状动脉旁路移植术治疗6例儿童川崎病并发冠状动脉病变 被引量:2

Coronary artery bypass grafting for coronary disease due to Kawasaki disease
原文传递
导出
摘要 目的 总结冠状动脉旁路移植治疗儿童川崎病并发冠状动脉病变的近、中期疗效.方法 2005年2月至2009年9月,6例川崎病并发冠状动脉病变病儿接受冠状动脉旁路移植,其中男5例,女1例 年龄6~12岁.确诊川崎病0.5~5.0年.冠状动脉左主干闭塞1例,左、右冠状动脉瘤样病变5例.心功能(NYHA)分级Ⅱ级1例,Ⅲ级5例.术前心脏超声示左室舒张末内径(LVDD)39~54 mm 左室收缩未内径(LVSD)23~45 mm 左室射血分数(LVEF)0.33~0.71 二尖瓣中度反流1例.均在体外循环下手术,移植血管均用动脉,平均旁路移植血管(2.0±0.6)根.其中左乳内动脉4根,桡动脉7根.同期冠状动脉成形术4例,二尖瓣成形术1例.结果 无手术死亡,体外循环平均(95.6±31.0)min 主动脉阻断平均(57.8±33.9)min.术后LVDD 32~56 mm,LVSD 21~39 mm,LVEF 0.45~0.71.冠状动脉CT示移植血管均通畅.均获随访,无远期死亡,病儿生长发育同正常同龄儿.随访0.1~4.5年,心功能平均(1.4±0.55)级.5例术后1年移植血管100%通畅,1例术后2年移植血管通畅.结论 冠状动脉旁路移植术可以有效治疗川崎病并发冠状动脉病变,全动脉化有利于旁路血管远期通畅,其近、中期疗效满意. Objective To determine the efficacy of coronary artery bypass grafting (CABG) in children with coronary obstructive disease subsequent to Kawasaki disease. Methods Between Feb 2005 and Sep 2009, 6 children with ischemic heart disease due to Kawasaki disease comprised the study group. The age of patients at operation was ranged from 6 to 12 years with a mean of ( 8.0 ± 2.3 ) years. The preoperative EF was ranged from 0.33 to 0.71 with a mean of 0.57 ± 0.15. There was one case with moderate mitral valve regurgitation. Results All patients survived the procedures. The mean number of bypass graft was 2.0 ±0.6,with 4 internal thoracic arteries and 7 radial arteries. Mitral valve repair was employed in 1 case. The cardisc function ( NYHA and EF) was significantly improved postoperatively. Postoperative CTA showed no graft disease in all cases. Conclusion CABG using the arterial grafts can provide attractive mid-term results in patients with obstructive coronary arteries associated with Kawasaki disease.
出处 《中华胸心血管外科杂志》 CSCD 北大核心 2010年第5期322-324,共3页 Chinese Journal of Thoracic and Cardiovascular Surgery
关键词 冠状动脉分流术 黏膜皮肤淋巴结综合症 心肌缺血 Coronary artery bypass Mucocutaneous lymph node sydrome Myocardial ischemia
  • 相关文献

参考文献21

  • 1Kawasaki T.Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children.Jpn J Allergy,1967,16:178 -222.
  • 2Leung DYM.Kawasaki disease.Curr Opin Rheumatol,1993,5:41 -50.
  • 3Ishiwata S,Katsuo F,Nishiyama S,et al.Adult coronary artery disease secondary to Kawasaki disease in childhood.Am J Cardiol,1992,69:692-694.
  • 4Kato H,Sugimura T,Akagi T,et al.Long-term consequences of Kawasaki disease A 10-to 21-year follow-up study of 594 patients.Circulation,1996,94:1379-1385.
  • 5Tatara K,Kusakawa S.Long-term prognosis of giant coronary aneurysm in Kawasaki disease:An angiographic study.J Pediatr,1987,111:705 -710.
  • 6Hwong TM,Arifi AA,Wan IY,et al.Rupture of a giant coronary artery aneurysm due to Kawasaki disease.Ann Thorac Surg,2004,78:693-695.
  • 7Kato H,Kitamura S,Kawasaki T.Guidelines for treatment and management of cardiovascular sequelae in Kawasaki disease.Heart Vessels,1987,3:50-54.
  • 8Kato H,Ichinose E,Kawasaki T.Myocardial infarction in Kawasaki disease:clinical analysis of 195 cases.J Pediatr,1986,108:923-927.
  • 9Tanaka H,Narisawa T,Hirano J,et al.Coronary artery bypass grafting for coronary aneurysms due to Kawasaki disease.Ann Thorac Cardiovasc Surg,2001,7:307-310.
  • 10Yamauchi H,Ochi M,Fujii M,et al.Optimal time of surgical treatment for Kawasaki coronary artery disease.J Nippon Med Sch,2004,71:279-286.

同被引文献44

  • 1无,赵晓东(整理),杜忠东(整理).川崎病专题讨论会纪要[J].中华儿科杂志,2007,45(11):826-830. 被引量:149
  • 2Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki dis- ease: a statement for health professionals from the Commit- tee on Rheumatic Fever, Endocarditis and Kawasaki Dis- ease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Circulation, 2004, 110(17): 2747-2771.
  • 3Senzaki H. Long-term outcome of Kawasaki disease[J]. Circulation, 2008, 118(25):2763-2772.
  • 4Scuccimarri R. Kawasaki disease[J]. Pediatr Clin North Am, 2012, 59(2):425-445.
  • 5Hsieh KS, Weng KP, Lin CC, et al. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisit- ed[J]. Pediatrics, 2004, 114(6):e689-e693.
  • 6Juan CC, Hwang B, Lee PC, et al. The clinical manifesta- tions and risk factors of a delayed diagnosis of Kawasaki disease[J]. J Chin Med Assoc, 2007, 70(9):374-379.
  • 7Berard R, Whittemore B, Scuceimarri R. Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 eases[J]. Pedi- atr Rheumatol Online J, 2012, 10(1):10.
  • 8Gordon DJ, Sloan SR, De Jong JL. A pediatric ease series of acute hemolysis after administration of intravenous im- munoglobulin[J]. Am J Hematol, 2009, 84(11):771-772.
  • 9Rigante D, Valentini P, Rizzo D, et al. Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome[J]. Rheumatol Int, 2010, 30(6):841-846.
  • 10Sakata K, Hamaoka K, Ozawa S, et al. A randomized prospective study on the use of 2 g-IVIG or I g-IVIG as therapy for Kawasaki disease[J]. Eur J Pcdiatr, 2007, 166 (6):565-571.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部